We are pleased to announce that the 4th International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment is tentatively scheduled on 16-17 October 2018 in Rockville, Maryland, USA.
- The meeting materials of the 2017 edition are available HERE.
The understanding of the human microbiome continues to grow rapidly; however information on the role of the microbiome on HIV infection pathogenesis, prevention, and treatment is still limited. Whereas research in this area may be presented at major conferences, there are often limited sessions devoted to this topic as well as limited time for in-depth discussion and debate among cross-disciplinary experts on new data and their implications. The aim of this workshop is to provide increased opportunities for discussion and exchange of knowledge following formal presentation of the latest research.
The multidisciplinary nature and the significance in furthering our ability to develop novel prevention and therapeutic strategies for HIV will lead to the reduction of new HIV infections and the burden of non-communicable diseases in HIV infected subjects. We also will be able to learn how the host microbiome can influence responses to our current HIV therapies.
This 2 day event will have invited lectures by key opinion leaders, oral abstract presentations and poster presentations. Ample time will be allocated for discussion in an intimate workshop setting. The conference will be unique in its approach, as it will engage basic scientists and clinicians from the HIV field and leading scientists involved in microbiome research including bioinformatics experts.
Clinicians and researchers with an interest in Microbiome in HIV Pathogenesis, Prevention and Treatment are most welcome to attend this workshop.
We look forward to seeing you in October 2018.
- To gather cross disciplinary professionals in the field of Microbiome
research to provide a better understanding of the impact of microbiome
changes on HIV outcomes
- To develop a better understanding of how the microbiome effects the
pathogenesis of HIV across mucosal sites
- To enhance our knowledge of how the microbiome can impact vaccine
- To better understand how the microbiome can contribute to the
development of non-communicable diseases
- To use our knowledge of the microbiome field in developing novel
strategies for developing microbicides for HIV prevention
- To bring together scientists from across the globe to enhance our
understanding of how we can use approaches to modulate the
microbiome to reduce levels of inflammation
- To bring together bioinformatics experts in enhancing our ability to
analyze complex data generated by sequencing the host microbiome
UNIQUE MEETING FEATURES
The meeting features for the workshop are to its multidisciplinary nature and significance in enabling to learn how the host microbiome can influence responses to our current HIV therapies, and to further our ability to develop novel prevention and therapeutic strategies for HIV that will lead to the reduction of new HIV infections and the burden of non-communicable diseases in HIV infected subjects.
Clinicians and researchers with interest in Microbiome in general and Pathogenesis in relation with HIV.